About US
Contact us
-
Daiichi Sankyo scores $182M from Novartis settlement in long-running patent caseAfter years of back and forth with Daiichi Sankyo over cancer drug patent claims, Novartis has thrown in the towel with a $182 million settlement. The case stems back to2017and has its roots in Novar2023/11/30
-
For Merck, Lynparza fails to improve on Keytruda in first-line lung cancerMerck has called it quits on another attempt to enhance its powerful PD-1 inhibitor Keytruda in non-small cell lung cancer (NSCLC). Adding AstraZeneca-partnered Lynparza to Keytruda as a maintenance2023/11/28
-
Novartis hit with FDA letter detailing 'significant' Kymriah manufacturing shortfallsWhen it comes to manufacturing cell therapies, it's often said that the "process is the product." But churning out these complex, individualized drugs has routinelytripped up even the industry's larg2023/11/28
-
Lilly's Jaypirca blazes leukemia trail with FDA nod, fast confirmatory trial filingAs AbbVie, Johnson & Johnson,AstraZeneca and BeiGene are battling it out in the same BTK inhibitor market, Eli Lilly is trailblazing a new path for the blood cancer drug class. On Friday, Dec.1,2023/11/23
-
Contract manufacturing giant WuXi Bio's stock plummets as it warns of $400M revenue missA challenging year for the biotech industry has taken a heavy toll on Chinese manufacturer WuXi Biologics, sending the company’s stock plummeting nearly 24% Monday. Meanwhile, the greater contract de2023/11/23
-
South Africa's Aspen expands reach with $100M buy of Sandoz's Chinese businessSouth Africa’s Aspen Pharmacare is growing its global footprint with a new agreement, worth up to 92.6 million euros ($100.3 million), to buy Sandoz’s China operations. The dealincludescommercializat2023/11/21
-
Lawmakers want to know why it took the FDA so long to rule on decongestant phenylephrineLast year, roughly 250 products that contain the decongestant phenylephrine—including popular brands such as Sudafed, NyQuil, Benadryl and Tylenol—rang up sales of nearly $1.8 billion. Just one probl2023/11/21
-
High-flying Fujifilm splashes $200M to beef up cell therapy capacityFujifilm Corporation is spreading the wealth across two production units as the contract development and manufacturing organization (CDMO) juggernaut works through a cell therapy expansion. The paren2023/11/16
-
Oxford Biomedica strikes €15M deal to acquire French CDMO ABL EuropeOxford Biomedica agreed to acquire French CDMO ABL Europe, a subsidiary of Institut Mérieux, for15 million euros($16 million) in a deal that will give the drugmaker expanded viral vector capabilities2023/11/16
-
Texas AG Paxton fires off another lawsuit at Pfizer, this one over the company's COVID-19 vaccineTexas Attorney General Ken Paxton is going after Pfizer—again. Less than two weeks after documents were unsealed showing that Texas has accused Pfizer and manufacturer Tris Pharma of providing a2023/11/14